• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

AbbVie (NY:ABBV)

210.39 -0.38 (-0.18%)
Official Closing Price Updated: 7:00 PM EDT, May 15, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,385,051
Open 213.10
Bid (Size) 209.60 (200)
Ask (Size) 212.00 (300)
Prev. Close 210.77
Today's Range 209.02 - 214.92
52wk Range 180.25 - 244.81
Shares Outstanding N/A
Dividend Yield 3.29%
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
2 Reasons to Like ABBV and 1 to Stay Skeptical
May 15, 2026
Over the past six months, AbbVie’s shares (currently trading at $211.15) have posted a disappointing 9.8% loss, well below the S&P 500’s 11.5% gain. This mig... 
Via StockStory
Topics Stocks Supply Chain
News headline image
5 Stocks to Own For the Next 10 Years ↗
May 14, 2026
All High Quality Names 
Via The Motley Fool

Performance

YTD
-8.3%
-8.3%
1 Month
+0.7%
+0.7%
3 Month
-9.6%
-9.6%
6 Month
-10.1%
-10.1%
1 Year
+14.3%
+14.3%

More News

Read More
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
Via Investor Brand Network
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
Via Investor Brand Network
InvestorNewsBreaks – SureNano Science Ltd. (CSE: SURE) (OTCQB: SURNF) Featured in BioMedWire Editorial on Next-Generation GLP-1 Innovation
May 13, 2026
Via Investor Brand Network
InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Next-Generation CNS Drug Delivery
May 13, 2026
Via Investor Brand Network
Topics Intellectual Property
News headline image
Next-Generation GLP-1 Innovation Could Unlock Massive Metabolic Healthcare Market Opportunities
May 13, 2026
From BioMedWire
Via GlobeNewswire
News headline image
3 Reasons to Buy AbbVie Stock (ABBV) Like There's No Tomorrow ↗
May 12, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
CNS Drug Delivery Technologies Are Reshaping Alzheimer’s and Biodefense Research
May 13, 2026
From BioMedWire
Via GlobeNewswire
News headline image
A Tiny Biotech Just Beat AbbVie's $17 Billion Drug. Should Investors Be Worried? ↗
May 11, 2026
Via The Motley Fool
News headline image
2 Cash-Producing Stocks to Research Further and 1 We Find Risky
May 11, 2026
Via StockStory
News headline image
What This Fund’s $4 Million Apollo Commercial Real Estate Finance Sale Could Signal About CRE Risk ↗
May 10, 2026
Via The Motley Fool
Topics Regulatory Compliance
News headline image
What to Know About This Fund’s $3 Million Blackstone Mortgage Trust Sale Amid Office Stress ↗
May 10, 2026
Via The Motley Fool
News headline image
AbbVie Touts Record Sales and Pipeline Momentum at Annual Meeting ↗
May 09, 2026
Via MarketBeat
News headline image
Safer Dividend King to Buy Now: AbbVie or Johnson & Johnson? ↗
May 06, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
Want Reliable Dividend Income in May? These 2 Stocks Deliver ↗
May 06, 2026
Via The Motley Fool
Topics Economy Intellectual Property
News headline image
5 Must-Read Analyst Questions From AbbVie’s Q1 Earnings Call
May 06, 2026
Via StockStory
Topics Earnings
News headline image
Want to Collect a High Dividend Every Month? Invest in These 3 Stocks ↗
May 05, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie's Latest Results Reveal a Trend Investors Shouldn't Overlook ↗
May 04, 2026
Via The Motley Fool
News headline image
3 of the Best Dividend Stocks to Buy in May 2026 ↗
May 04, 2026
Via The Motley Fool
Topics Intellectual Property
News headline image
The Best Stocks to Buy With $1,000 Right Now ↗
May 03, 2026
Via The Motley Fool
Topics Artificial Intelligence Earnings
News headline image
The Most Important Part of These 3 Big Pharma Earnings Reports Wasn’t the Beat ↗
May 02, 2026
Via MarketBeat
News headline image
MarketBeat Week in Review – 04/27 - 05/01 ↗
May 02, 2026
Via MarketBeat
News headline image
Aqua Medical Spa Launches New Website to Showcase Aesthetic and Wellness Services in London, ON
May 01, 2026
Via GetFeatured
News headline image
ABBV Q1 Deep Dive: Immunology and Neuroscience Growth, Raised Full-Year Outlook
April 30, 2026
Via StockStory

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 210.39
When was AbbVie last traded?
The last trade of AbbVie was at 05/15/26 07:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap